Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Fortress Biotech (FBIO) Operating Margin (2016 - 2025)

Historic Operating Margin for Fortress Biotech (FBIO) over the last 12 years, with Q3 2025 value amounting to 38.63%.

  • Fortress Biotech's Operating Margin rose 1124000.0% to 38.63% in Q3 2025 from the same period last year, while for Sep 2025 it was 143.55%, marking a year-over-year increase of 261500.0%. This contributed to the annual value of 191.38% for FY2024, which is 229500.0% down from last year.
  • As of Q3 2025, Fortress Biotech's Operating Margin stood at 38.63%, which was up 1124000.0% from 222.22% recorded in Q2 2025.
  • In the past 5 years, Fortress Biotech's Operating Margin registered a high of 38.63% during Q3 2025, and its lowest value of 473.63% during Q1 2023.
  • For the 5-year period, Fortress Biotech's Operating Margin averaged around 226.23%, with its median value being 236.77% (2021).
  • Within the past 5 years, the most significant YoY rise in Fortress Biotech's Operating Margin was 2673700bps (2023), while the steepest drop was -2760500bps (2023).
  • Quarter analysis of 5 years shows Fortress Biotech's Operating Margin stood at 339.25% in 2021, then increased by 2bps to 333.05% in 2022, then surged by 70bps to 98.34% in 2023, then plummeted by -60bps to 157.64% in 2024, then soared by 75bps to 38.63% in 2025.
  • Its last three reported values are 38.63% in Q3 2025, 222.22% for Q2 2025, and 169.85% during Q1 2025.